GO:0097526 spliceosomal tri-snRNP complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097526 (spliceosomal tri-snRNP complex) is a cellular_component defined as a spliceosomal snRNP complex formed by the association of the U4/U6 (or U4atac/U6atac) snRNP with the U5 snRNP.
• The human tri-snRNP is a large ribonucleoprotein machine whose architecture has been resolved by cryo-EM, revealing how U5, U4/U6 snRNAs and associated proteins are organized.
• The tri-snRNP is a central intermediate in spliceosome assembly and is remodeled during the cross-exon to cross-intron spliceosome switch.
• The minor spliceosome uses an analogous U4atac/U6atac.U5 tri-snRNP to engage U12-type introns, as shown by the fully assembled human minor spliceosome structure.
• Variants in U4 and U6 snRNA genes that are integral to the tri-snRNP cause retinitis pigmentosa, and RNU4-2 variants cause a frequent neurodevelopmental syndrome [1,7,8].
• Tri-snRNP components and their regulation are tractable targets for CRISPR knockout, point-mutation, knock-in and overexpression models in disease and splicing research [1,3,5].
Description
The spliceosomal tri-snRNP complex (GO:0097526) is a cellular_component that forms when the U4/U6 (or U4atac/U6atac) snRNP associates with the U5 snRNP. This tri-snRNP is a pre-assembled building block that is recruited to the spliceosome during the transition from the cross-exon to the cross-intron configuration, a step that is essential for catalytic activation of splicing. Because it concentrates three snRNAs and dozens of proteins into one particle, the tri-snRNP is a focal point for understanding how splice sites are recognized and how splicing is regulated. The tri-snRNP is not a static entity. Its architecture has been determined by cryo-electron microscopy, showing how U5 and U4/U6 snRNAs are held together by protein scaffolds and how the particle is poised for subsequent rearrangements. Structural work on the fully assembled human minor spliceosome has extended these principles to the U12-type system, where the analogous U4atac/U6atac.U5 tri-snRNP engages minor-class introns. These studies place GO:0097526 at the intersection of RNA biology, structural biology and human genetics. Clinically, the tri-snRNP is increasingly recognized as a disease-relevant machine. De novo variants in RNU4-2, an snRNA gene that functions within the U4/U6 context, cause a frequent neurodevelopmental syndrome [1,2], and dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa [7,8]. Researchers therefore study GO:0097526 to connect spliceosome structure to Mendelian disease and to identify therapeutic entry points.
spliceosomal tri-snRNP complex At A Glance
| GO ID | GO:0097526 |
|---|---|
| GO term | spliceosomal tri-snRNP complex |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Pre-assembled U4/U6.U5 (or U4atac/U6atac.U5) snRNP particle that is recruited to the spliceosome and remodeled during catalytic activation [3,5] |
| Composition | U4, U6 and U5 snRNAs (or U4atac, U6atac and U5 snRNAs) plus associated proteins including Sm/LSm and tri-snRNP-specific factors [5,6] |
| Assembly context | Formed by association of the U4/U6 (or U4atac/U6atac) snRNP with the U5 snRNP |
| Related process | Pre-mRNA splicing via the major and minor spliceosomes [3,6] |
| Disease relevance | Variants in U4/U6 snRNA genes cause retinitis pigmentosa and RNU4-2 variants cause a neurodevelopmental syndrome [1,7,8] |
What Is GO:0097526?
GO:0097526 describes the spliceosomal tri-snRNP complex: a spliceosomal small nuclear ribonucleoprotein (snRNP) complex that is formed by the association of the U4/U6 (or U4atac/U6atac) snRNP with the U5 snRNP. In other words, it is the three-snRNA particle (U4, U6 and U5 in the major spliceosome; U4atac, U6atac and U5 in the minor spliceosome) that serves as a pre-assembled unit for spliceosome assembly and activation [3,5,6].
Why Is spliceosomal tri-snRNP complex Important in Cell Biology?
GO:0097526 is important because the tri-snRNP is the pre-assembled three-snRNA module that the spliceosome uses to transition from splice-site recognition to catalysis, and its structural integrity is required for normal pre-mRNA splicing [3,5]. Because the same particle is used by the major and minor spliceosomes, it influences both canonical and U12-type intron processing. Human genetics has now linked tri-snRNP snRNA components to neurodevelopmental disease and retinal degeneration, making this complex a direct bridge between basic RNA biology and clinical phenotypes [1,2,7,8].
• Defines the U4/U6.U5 (and U4atac/U6atac.U5) particle that is recruited to the spliceosome during assembly.
• Provides the structural framework for the cross-exon to cross-intron spliceosome switch.
• Supports both major and minor spliceosome pathways, including U12-type intron engagement.
• Is a hub for snRNA variants that cause retinitis pigmentosa [7,8].
• Is linked to RNU4-2-associated neurodevelopmental syndrome [1,2].
• Contains SUMOylation targets that connect splicing to post-translational regulation.
• Serves as a model system for cryo-EM studies of large RNP machines.
• Offers CRISPR-tractable targets for dissecting snRNA and protein function [1,3,5].
• Is relevant to splicing-based therapeutic strategies in genetic disease [1,7].
• Provides a defined GO entity for annotating spliceosome-related omics data [3,5].
Structure and Composition of spliceosomal tri-snRNP complex
Overall architecture of the U4/U6.U5 tri-snRNP
In simple terms: The tri-snRNP is a three-RNA machine that is held together by many proteins.
The architecture of the spliceosomal U4/U6.U5 tri-snRNP has been determined by cryo-electron microscopy, revealing how the U5 and U4/U6 snRNAs are organized within a single particle and how protein components scaffold the RNA elements. This structural framework explains how the tri-snRNP can be pre-assembled and then remodeled upon integration into the spliceosome.
snRNA components: U4, U6 and U5
In simple terms: Three small RNAs, U4, U6 and U5, are the core RNAs of the particle.
GO:0097526 is defined by the association of the U4/U6 snRNP with the U5 snRNP, meaning that U4, U6 and U5 snRNAs are the defining RNA constituents of the major tri-snRNP. In the minor spliceosome, the analogous particle contains U4atac, U6atac and U5 snRNAs, as shown by the structure of the fully assembled human minor spliceosome.
Protein composition and RNP assembly
In simple terms: Dozens of proteins package the three snRNAs into a stable particle.
The tri-snRNP contains Sm/LSm proteins and tri-snRNP-specific factors that together stabilize the U4/U6 and U5 snRNPs in one complex. Structural analysis of the human minor spliceosome has similarly revealed the protein architecture that supports U4atac/U6atac.U5 assembly and U12-type intron engagement.
Role in the cross-exon to cross-intron switch
In simple terms: The tri-snRNP helps the spliceosome change from one assembly mode to another.
Structural insights into the cross-exon to cross-intron spliceosome switch show that the tri-snRNP is a key player in this transition, during which spliceosomal components are reorganized to form the catalytically relevant intron-defined complex. This places GO:0097526 at a decisive step in spliceosome maturation.
Minor spliceosome tri-snRNP
In simple terms: A related three-RNA particle works in the minor splicing system.
The fully assembled human minor spliceosome structure reveals how the U4atac/U6atac.U5 tri-snRNP engages U12-type introns, demonstrating that the tri-snRNP principle is conserved across spliceosome classes. This structural work clarifies how minor-class introns are recognized and processed.
Post-translational regulation of tri-snRNP components
In simple terms: Chemical tags on proteins can tune how the tri-snRNP works.
SUMOylation has been linked to splicing regulation, and the intersection of SUMO and splicing includes components of the spliceosomal machinery. This provides a regulatory layer that can influence tri-snRNP function beyond its core RNA-protein architecture.
Key Genes Involved in GO:0097526 spliceosomal tri-snRNP complex
The following genes and snRNA loci encode the RNA and protein components that define or directly support the spliceosomal tri-snRNP complex (GO:0097526).
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNU4-2 | U4 snRNA variant gene implicated in neurodevelopmental disease | De novo variants cause a frequent neurodevelopmental syndrome [1,2] |
| RNU4 | U4 snRNA component of the U4/U6 snRNP | Dominant variants cause retinitis pigmentosa [7,8] |
| RNU6 | U6 snRNA component of the U4/U6 snRNP | Dominant variants cause retinitis pigmentosa [7,8] |
| RNU5 | U5 snRNA component of the tri-snRNP | Core RNA of the U5 snRNP within GO:0097526 |
| RNU4ATAC | U4atac snRNA of the minor tri-snRNP | Minor spliceosome U4atac/U6atac.U5 assembly |
| RNU6ATAC | U6atac snRNA of the minor tri-snRNP | Minor spliceosome U4atac/U6atac.U5 assembly |
| PRPF8 | U5-associated protein in the tri-snRNP/spliceosome | Structural and functional studies of tri-snRNP architecture |
| SNRNP200 | U5 snRNP helicase component | Tri-snRNP remodeling and spliceosome activation |
| PRPF6 | Tri-snRNP protein bridging U4/U6 and U5 | Architecture of the U4/U6.U5 tri-snRNP |
| PRPF3 | U4/U6 snRNP protein | Tri-snRNP assembly and stability |
| PRPF4 | U4/U6 snRNP protein | Tri-snRNP assembly and stability |
| PRPF31 | U4/U6 snRNP protein | Tri-snRNP-related splicing and disease models |
| SNRPB | Sm core protein of snRNPs | snRNP biogenesis and tri-snRNP composition |
| SNRPD1 | Sm core protein of snRNPs | snRNP biogenesis and tri-snRNP composition |
| SNRPE | Sm core protein of snRNPs | snRNP biogenesis and tri-snRNP composition |
| LSM2 | LSm protein associated with U6 snRNA | U6 snRNP function within the tri-snRNP |
| LSM4 | LSm protein associated with U6 snRNA | U6 snRNP function within the tri-snRNP |
How Is spliceosomal tri-snRNP complex Regulated?
Regulation of the tri-snRNP occurs at multiple levels. Post-translational modification by SUMO has been connected to splicing control, providing a mechanism by which tri-snRNP-associated factors can be dynamically modulated. In addition, the tri-snRNP is regulated through its assembly and remodeling during the cross-exon to cross-intron spliceosome switch, a structural transition that determines when the particle becomes catalytically relevant. The presence of distinct major and minor tri-snRNPs further implies class-specific regulation of U12-type versus U2-type intron processing.
spliceosomal tri-snRNP complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNU4-2 | Neurodevelopmental syndrome (ReNU syndrome) | Knock-in of patient variants in cell models; KO of RNU4-2 locus [1,2] |
| RNU4 | Retinitis pigmentosa | Point-mutation knock-in of dominant U4 variants [7,8] |
| RNU6 | Retinitis pigmentosa | Point-mutation knock-in of dominant U6 variants [7,8] |
| RNU4ATAC | Minor spliceosome dysfunction | Knockout and rescue with U4atac variants |
| PRPF31 | Retinal degeneration / splicing dysfunction | Knockout and tagged knock-in for tri-snRNP studies |
RNU4-2 neurodevelopmental syndrome
De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome, establishing a direct link between a tri-snRNP-related snRNA and human neurodevelopment. Clinical study of patients with ReNU syndrome has further characterized the phenotypic spectrum associated with RNU4-2 variants.
Retinitis pigmentosa and U4/U6 snRNA variants
De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa, implicating core tri-snRNP snRNA components in retinal degeneration [7,8]. These findings connect GO:0097526 to a major inherited blindness phenotype [7,8].
Minor spliceosome and U12-type intron disease relevance
The fully assembled human minor spliceosome structure shows how the U4atac/U6atac.U5 tri-snRNP engages U12-type introns, providing a structural basis for understanding disease-linked defects in minor-class splicing.
Splicing regulation and SUMO pathways
The intersection of SUMOylation and splicing suggests that regulatory perturbations of tri-snRNP-associated factors could contribute to splicing-related pathology.
From spliceosomal tri-snRNP complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a tri-snRNP snRNA required for cell viability? | CRISPR knockout of the snRNA locus or associated protein gene [1,5] |
| Does a patient variant alter splicing? | Point-mutation knock-in of the variant followed by RNA-seq [1,7,8] |
| Where does a tri-snRNP protein localize? | Tagged knock-in with fluorescent or affinity tag |
| Can wild-type snRNA rescue a disease phenotype? | Knock-in or overexpression rescue in variant cells [1,6] |
| Which transcripts depend on the minor tri-snRNP? | Knockout of U4atac/U6atac components plus RNA-seq |
| Does SUMOylation regulate tri-snRNP function? | Point mutation of SUMO sites in tri-snRNP proteins |
How to Study the spliceosomal tri-snRNP complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of the tri-snRNP | Architecture of U4/U6.U5 and minor tri-snRNP [5,6] |
| RNA-seq | Splicing changes and intron retention | Variant impact on splicing [1,7,8] |
| Mass spectrometry | Protein composition of RNP particles | Tri-snRNP interactome |
| CRISPR knockout | Loss-of-function phenotype | Requirement for tri-snRNP components [1,5] |
| Point-mutation knock-in | Effect of specific disease variants | U4/U6 and RNU4-2 variant modeling [1,7,8] |
| Fluorescence imaging | Localization of tagged tri-snRNP proteins | Nuclear speckle and spliceosome dynamics |
| SUMOylation assays | Post-translational modification of splicing factors | Regulation of tri-snRNP function |
| Clinical genomics | Variant discovery in patient cohorts | Gene-disease association [1,2,7,8] |
Structural biology of the tri-snRNP
Cryo-electron microscopy has been used to determine the architecture of the spliceosomal U4/U6.U5 tri-snRNP, revealing the spatial organization of its snRNAs and proteins. Similar approaches resolved the fully assembled human minor spliceosome, showing how the U4atac/U6atac.U5 tri-snRNP engages U12-type introns.
RNA-seq and splicing assays
RNA sequencing is used to detect splicing changes caused by variants in tri-snRNP components, as demonstrated for RNU4-2 and U4/U6 snRNA variants linked to disease [1,7,8]. These assays connect molecular defects in GO:0097526 to transcriptome-wide splicing outcomes [1,7,8].
Proteomics and RNP composition analysis
Mass spectrometry-based proteomics can define the protein composition of tri-snRNP particles and identify associated factors, complementing structural studies of the U4/U6.U5 complex. Such analyses help assign proteins to GO:0097526 and its subcomplexes.
Genetic and clinical genomics
Clinical exome and genome sequencing has identified de novo and inherited variants in U4 and U6 snRNA genes in retinitis pigmentosa and in RNU4-2 in neurodevelopmental syndrome, linking genotype to tri-snRNP biology [1,2,7,8].
How CRISPR Can Be Used to Study GO:0097526 spliceosomal tri-snRNP complex
Knockout
CRISPR knockout of tri-snRNP protein genes or snRNA loci can test whether a component is required for splicing and cell viability, and can be used to define the functional contribution of individual factors within GO:0097526 [1,5].
Point Mutation
Point-mutation knock-in allows precise modeling of disease-associated variants in U4, U6 or RNU4-2, enabling RNA-seq-based assessment of splicing defects caused by altered tri-snRNP components [1,7,8].
Knock-in
Tagged knock-in of tri-snRNP proteins supports localization, interaction and structural studies, while rescue knock-in of wild-type snRNA can test whether a disease phenotype is reversible [1,5,6].
Overexpression
Overexpression of wild-type or mutant tri-snRNP components can reveal dominant effects on splicing and help distinguish gain-of-function from loss-of-function mechanisms in disease [1,7,8].
How EDITGENE Supports spliceosomal tri-snRNP complex Research
Researchers studying spliceosomal tri-snRNP complex-related genes often need to determine whether a candidate gene is causally involved in splicing regulation or disease, and CRISPR-based models provide a direct way to test that causality in relevant cell types [1,3,5].
Contact EDITGENE today to design your custom CRISPR model for spliceosomal tri-snRNP complex research.
Frequently Asked Questions About spliceosomal tri-snRNP complex
What is GO:0097526?
GO:0097526 is the Gene Ontology cellular_component term for the spliceosomal tri-snRNP complex, defined as a spliceosomal snRNP complex formed by the association of the U4/U6 (or U4atac/U6atac) snRNP with the U5 snRNP.
What is the spliceosomal tri-snRNP complex?
It is a three-snRNA ribonucleoprotein particle containing U4, U6 and U5 snRNAs (or U4atac, U6atac and U5 in the minor spliceosome) that is pre-assembled for spliceosome assembly and activation [3,5,6].
What genes are involved in the spliceosomal tri-snRNP complex?
Key genes and loci include RNU4-2, RNU4, RNU6, RNU5, RNU4ATAC, RNU6ATAC and protein genes such as PRPF8, SNRNP200, PRPF6, PRPF3, PRPF4 and PRPF31 [1,5,6,7,8].
What does the tri-snRNP do in splicing?
It is recruited to the spliceosome and remodeled during the cross-exon to cross-intron switch, a step required for catalytic activation of pre-mRNA splicing [3,5].
How is the tri-snRNP structured?
Cryo-EM studies have revealed the architecture of the U4/U6.U5 tri-snRNP, showing how its snRNAs and proteins are organized within one particle.
Is there a minor spliceosome tri-snRNP?
Yes, the minor spliceosome uses a U4atac/U6atac.U5 tri-snRNP, as shown by the structure of the fully assembled human minor spliceosome engaging U12-type introns.
Which diseases are linked to tri-snRNP components?
Variants in U4 and U6 snRNA genes cause retinitis pigmentosa, and RNU4-2 variants cause a frequent neurodevelopmental syndrome [1,2,7,8].
How can CRISPR be used to study GO:0097526?
CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression can test the function of tri-snRNP snRNAs and proteins in splicing and disease models [1,5,7,8].
What methods study the tri-snRNP complex?
Cryo-EM, RNA-seq, mass spectrometry, fluorescence imaging and clinical genomics are commonly used to study tri-snRNP structure, composition and disease impact [1,5,6,7,8].
Why is the tri-snRNP important for human health?
Because it is essential for pre-mRNA splicing and its snRNA components are mutated in neurodevelopmental disease and retinal degeneration, making it a direct link between RNA machinery and human disease [1,2,7,8].
Conclusion
GO:0097526 (spliceosomal tri-snRNP complex) defines the pre-assembled U4/U6.U5 (or U4atac/U6atac.U5) particle that is central to spliceosome assembly and activation [3,5,6]. Its structure, composition and regulation are increasingly well understood, and its snRNA components are directly implicated in neurodevelopmental syndrome and retinitis pigmentosa [1,2,7,8]. For researchers, the tri-snRNP offers a defined and CRISPR-tractable system for dissecting splicing mechanisms and disease variants. Combining structural, transcriptomic and genetic approaches will continue to clarify how this complex contributes to normal RNA processing and to human pathology [1,3,5,6,7,8].
References
- 1. Chen Y et al.. 2024. De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome.. Nature 632(8026):832-840 PMID: 38991538
- 2. Okamoto N et al.. 2025. A Clinical Study of Nine Patients With ReNU Syndrome.. Am J Med Genet A 197(11):e64151 PMID: 40546132
- 3. Zhang Z et al.. 2024. Structural insights into the cross-exon to cross-intron spliceosome switch.. Nature 630(8018):1012-1019 PMID: 38778104
- 4. Pozzi B et al.. 2018. When SUMO met splicing.. RNA Biol 15(6):689-695 PMID: 29741121
- 5. Nguyen TH et al.. 2015. The architecture of the spliceosomal U4/U6.U5 tri-snRNP.. Nature 523(7558):47-52 PMID: 26106855
- 6. Bai R et al.. 2024. Structural basis of U12-type intron engagement by the fully assembled human minor spliceosome.. Science 383(6688):1245-1252 PMID: 38484052
- 7. Quinodoz M et al.. 2026. De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa.. Nat Genet 58(1):169-179 PMID: 41513982
- 8. Quinodoz M et al.. 2025. De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa.. medRxiv PMID: 39830270
